Clinical pharmacokinetics of alpha 1-antitrypsin in homozygous PiZ deficient patients.
Clin Pharmacokinet
; 23(2): 161-8, 1992 Aug.
Article
en En
| MEDLINE
| ID: mdl-1511530
ABSTRACT
A pharmacokinetic study of alpha 1-antitrypsin (ATT) was performed in 2 groups of homozygous PiZ-deficient patients (treated and untreated) and 1 group of healthy volunteers. The distribution of the 131I-labelled protein corresponds to a 3-compartment model. The intravenously administered protein diffused quickly to the extravascular compartment where some retention occurred. No significant difference in AAT metabolism was observed between the 3 groups. The half-life of the injected protein is slightly longer than 2.5 days. The AAT protein was not stored. These results confirm the observations collected during the clinical trials. That is, a weekly infusion is necessary to obtain stable serum AAT concentrations. Monthly infusions are unable to maintain a 'plateau' phase. The periodicity may be limited to every 2 weeks.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Alfa 1-Antitripsina
/
Deficiencia de alfa 1-Antitripsina
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Clin Pharmacokinet
Año:
1992
Tipo del documento:
Article
País de afiliación:
Francia